{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/31/3303919/0/en/Revolution-Medicines-Announces-ASCO-Plenary-Presentation-Highlighting-Unprecedented-Results-from-Pivotal-Phase-3-RASolute-302-Clinical-Trial-of-Daraxonrasib-in-Previously-Treated-M.html", "message": "News view counter 769194 successfully enlarged"}